Xtant Reports 1Q19 Revenue of $16.7MM, -7% vs. 1Q18

by Mike Evers on May 17, 2019

Xtant reports 1Q19 revenue of USD $16.7MM, -7% vs. 1Q18.

Added 12 new distributors over the last four months
Declining revenues attributable to continued struggles with spinal hardware sales
Focused on cutting costs to generate sufficient cash to fund operations

ORTHOWORLD estimates segment sales and growth...

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

	1Q19	1Q18	$ Chg	% Chg
Spine	$5.7	$6.5	-$0.8	-12.1%
Orthobiologics	$11.0	$11.5	-$0.5	-4.1%
*Total*	*$16.7*	*$17.9*	*-$1.2*	*-7.0%*

Geographic Region	1Q19	1Q18	$ Chg	% Chg
US	$16.0	$17.2	-$1.2	-6.7%
Ex-US	$0.7	$0.8	-$0.1	-12.2%
Total	$16.7	$17.9	-$1.2	-7.0%

1Q19	Amount	% of Sales
Sales	$16.7
Cost of Sales	-$5.9	35.4%
General and Admin	-$4.2	25.1%
Sales and Marketing	-$6.7	40.4%
R & D	-$0.3	1.6%
Other	-$2.4	14.2%
Net Earnings	-$2.8	-16.8%

	1Q19	1Q18	$ Chg	% Chg
Spine	$5.7	$6.5	-$0.8	-12.1%
Orthobiologics	$11.0	$11.5	-$0.5	-4.1%
*Total*	*$16.7*	*$17.9*	*-$1.2*	*-7.0%*

Geographic Region	1Q19	1Q18	$ Chg	% Chg
US	$16.0	$17.2	-$1.2	-6.7%
Ex-US	$0.7	$0.8	-$0.1	-12.2%
Total	$16.7	$17.9	-$1.2	-7.0%

Xtant Reports 1Q19 Revenue of $16.7MM, -7% vs. 1Q18

Orthofix Growth Driven by Trauma and BGT Sales

CONMED in Later Innings of Ortho Supply Turnaround

Orthopedic Companies Report Results from Third Quarter 2025

Zimmer Biomet Drives Strong Quarter Despite Noise in Non-Core Areas

ATEC Exceeds Expectations, Fueled by New Catalysts

Get the ORTHOWORLD Newsletter!

Contact Us